RxDoctor Payments Data

Abel Arzu, PA

Physician Assistant · Moore, OKNPI 1972361087

Payments from drug & device makers

$539in general payments, 2019–2025

Across 19 payments — averaging $28.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$227
  • UCB, Inc.$75
  • CSL Behring$72
  • Argenx US, Inc.$31
  • Eisai Inc.$28
  • AbbVie$28
  • plus $79 from 4 others

What the payments were for

  • Food & beverage$539100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)7$227
UCB, Inc.2$75
CSL Behring3$72
Argenx US, Inc.1$31
Eisai Inc.1$28
AbbVie1$28
Amgen1$24
Astellas Pharma US Inc1$20
GE HealthCare1$18
Pfizer1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$539 in reported general payments places this provider in the 60th percentile of 1,491 physician assistant providers in Oklahoma.

See all physician assistant providers in Oklahoma

Medicare billing

Part B allowed, 2024
$21,622
Medicare patients
127
Services billed
368

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cyclobenzaprine Hcl13$57

Paid to pharmacies, not to this prescriber.

Other physician assistant in Moore

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →